Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-time vs single-breath EtO2 for pre-oxygenation
NCT03840486Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2019
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypoxemia (2 arms), sponsored by Emory University. Primary endpoint: End-tidal Oxygen at 3 minutes. Started Sep 2019; status: completed.
02
Conditions
hypoxemia
Beyond the preview
Go deeper on NCT03840486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840486.